13F HOLDINGS REPORT
Tri Locum Partners LP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001826434-24-000006
Total Value
$395.5M
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 2,550,307 | $41.4M | 10.48% |
| 2 | ARGENX SE | ARGX | 74,558 | $32.1M | 8.11% |
| 3 | ASCENDIS PHARMA A/S | ASND | 227,762 | $31.1M | 7.85% |
| 4 | AMGEN INC | AMGN | 82,271 | $25.7M | 6.50% |
| 5 | NATERA INC | NTRA | 230,585 | $25.0M | 6.31% |
| 6 | AXSOME THERAPEUTICS INC | AXSM | 306,513 | $24.7M | 6.24% |
| 7 | INSMED INC | INSM | 316,501 | $21.2M | 5.36% |
| 8 | MERUS N V | N5749R100 | 335,514 | $19.9M | 5.02% |
| 9 | REGENERON PHARMACEUTICALS | REGN | 17,516 | $18.4M | 4.65% |
| 10 | MADRIGAL PHARMACEUTICALS INC | MDGL | 65,352 | $18.3M | 4.63% |
| 11 | INSPIRE MED SYS INC | 457730109 | 133,276 | $17.8M | 4.51% |
| 12 | AVADEL PHARMACEUTICALS PLC | 05337M104 | 1,189,518 | $16.7M | 4.23% |
| 13 | PFIZER INC | PFE | 596,919 | $16.7M | 4.22% |
| 14 | UNITED THERAPEUTICS CORP DEL | UTHR | 50,100 | $16.0M | 4.04% |
| 15 | LEGEND BIOTECH CORP | LEGN | 356,532 | $15.8M | 3.99% |
| 16 | ALNYLAM PHARMACEUTICALS INC | ALNY | 45,000 | $10.9M | 2.76% |
| 17 | STEVANATO GROUP S P A | STVN | 565,422 | $10.4M | 2.62% |
| 18 | NOVO-NORDISK A S | NONOF | 63,811 | $9.1M | 2.30% |
| 19 | VAXCYTE INC | PCVX | 113,344 | $8.6M | 2.16% |
| 20 | XENON PHARMACEUTICALS INC | XENE | 101,959 | $4.0M | 1.01% |
| 21 | OCULAR THERAPEUTIX INC | OCUL | 514,642 | $3.5M | 0.89% |
| 22 | PRAXIS PRECISION MEDICINES I | PRAX | 75,319 | $3.1M | 0.79% |
| 23 | MIND MEDICINE MINDMED INC | 60255C885 | 382,055 | $2.8M | 0.70% |
| 24 | KORRO BIO INC | KRRO | 71,428 | $2.4M | 0.61% |
| 25 | FEMASYS INC | FEMY | 30,606 | $34,891 | 0.01% |